227 related articles for article (PubMed ID: 7684884)
21. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
Strugala V; Dettmar PW; Pearson JP
Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
[TBL] [Abstract][Full Text] [Related]
22. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Jenkins DG; Macey MG; Langmead L; Rampton DS
Am J Gastroenterol; 2008 Jun; 103(6):1460-9. PubMed ID: 18510607
[TBL] [Abstract][Full Text] [Related]
23. Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease.
Vizoso FJ; González LO; Corte MD; Corte MG; Bongera M; Martínez A; Martín A; Andicoechea A; Gava RR
Scand J Gastroenterol; 2006 Sep; 41(9):1050-5. PubMed ID: 16938718
[TBL] [Abstract][Full Text] [Related]
24. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
25. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
27. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
28. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
29. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
Yantiss RK; Odze RD
Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
[TBL] [Abstract][Full Text] [Related]
30. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease.
Indaram AV; Visvalingam V; Locke M; Bank S
Am J Gastroenterol; 2000 May; 95(5):1221-5. PubMed ID: 10811331
[TBL] [Abstract][Full Text] [Related]
31. In vitro IgE production by peripheral blood lymphocytes and rectal mucosal biopsies and antigen-induced basophil degranulation in patients with inflammatory bowel disease.
Smart C; Danis VA; Heatley RV
J Clin Lab Immunol; 1986 Aug; 20(4):183-5. PubMed ID: 3761355
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation.
McLaughlan JM; Seth R; Vautier G; Robins RA; Scott BB; Hawkey CJ; Jenkins D
J Pathol; 1997 Jan; 181(1):87-92. PubMed ID: 9072008
[TBL] [Abstract][Full Text] [Related]
33. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
[TBL] [Abstract][Full Text] [Related]
34. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
[TBL] [Abstract][Full Text] [Related]
35. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
Nielsen OH; Brynskov J; Bendtzen K
Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
[TBL] [Abstract][Full Text] [Related]
36. In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.
Danis VA; Harries AD; Heatley RV
Clin Exp Immunol; 1984 Apr; 56(1):159-66. PubMed ID: 6713728
[TBL] [Abstract][Full Text] [Related]
37. 'Microerosions' in rectal biopsies in Crohn's disease.
Poulsen SS; Pedersen NT; Jarnum S
Scand J Gastroenterol; 1984 Jul; 19(5):607-12. PubMed ID: 6474082
[TBL] [Abstract][Full Text] [Related]
38. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease.
Vitali R; Stronati L; Negroni A; Di Nardo G; Pierdomenico M; del Giudice E; Rossi P; Cucchiara S
Am J Gastroenterol; 2011 Nov; 106(11):2029-40. PubMed ID: 21788990
[TBL] [Abstract][Full Text] [Related]
39. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
[TBL] [Abstract][Full Text] [Related]
40. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
Zhang Z; Zhao X; Lv C; Li C; Zhi F
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
